Expanded sweetener molecule development program aims to broaden access to plant-based sweetening solutions tailored to diverse customer food and beverage categories. Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - May 18, 2026) - The ex... See more
The global artificial intelligence (AI) in drug discovery market is projected to grow from USD 1.86 billion in 2024 to USD 6.89 billion by 2029, registering a CAGR of 29.9% during the forecast period, according to a recent market research report published... See more
The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here, BioSpace reviews genetic medicines in development for the central nervous system, retinal, cardiac and neuromuscular diseases. Last ... See more
Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ Trodelvy showed promising results, while a complex combination by Agenus and MiNK Therapeutics failed to elicit an overall response. Com... See more
Zemědomy vypadají jako domy z jiné planety. Vyhlížejí ze země s organickou přirozeností, která působí hřejivě a podmanivě. Tyto unikátní a překvapivé stavby odrážejí charakter lidí, kteří je budují. Představují udržitelnou architekturu, jež lidstvo propoj... See more
